funded by National Natural Science Foundation of China(No.82273716);National Key Research and Development Program of China(2021YFA1101003);Young Eagle Project of Fourth Military Medical University(No.2020cyjhsq);National Natural Science Foundation of China(No.82172607 and 82273182).
Background Human interferon-α1b(hIFN-α1b)is the first genetically engineered drug approved by the National Medical Product Administration for cancer therapy in China.hIFN-α1b is a relatively safe therapy and can im...